In coronavirus disease 2019 (COVID‐19), higher morbidity and mortality are associated with
age, male gender, and comorbidities, such as chronic lung diseases, cardiovascular …

Among the plethora of debilitating neurological disorders of COVID-19 syndrome in
survivors, the scope of SARS-CoV-2-induced dysautonomia (DNS) is yet to be understood …

Key points The impact of SARS‐CoV‐2 infection on autonomic and cardiovascular function
in otherwise healthy individuals is unknown. For the first time it is shown that young adults …

In December 2019, a novel coronavirus-related disease (Covid-19) emerged in Wuhan,
China, caused by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). This …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative virus in the
development of coronavirus disease 2019 (Covid-19) pandemic. Respiratory manifestations …

Patients with long COVID suffer from many neurological manifestations that persist for 3
months following infection by SARS-CoV-2. Autonomic dysfunction (AD) or dysautonomia is …

Although autonomic dysfunction (AD) after the recovery from Coronavirus disease 2019
(COVID-19) has been thoroughly described, few data are available regarding the …

Long COVID is characterized by persistent signs and symptoms that continue or develop for
more than 4 weeks after acute COVID-19 infection. Patients with Long COVID experience a …

The pandemic viral illness COVID-19 is especially life-threatening in the elderly and in those
with any of a variety of chronic medical conditions. This essay explores the possibility that …

Background Previous studies suggest that coronavirus disease 2019 (COVID-19) is a
systemic infection involving multiple systems, and may cause autonomic dysfunction …